Supplementary Tables – Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib
dataset
posted on 2022-07-29, 08:22 authored by Figshare Future Science GroupFigshare Future Science Group, Dong-Hoon Lim, Andrea Casadei-Gardini, Myung Ah Lee, Sara Lonardi, Jin Won Kim, Gianluca Masi, Hong Jae Chon, Margherita Rimini, Ilhwan Kim, Jaekyung Cheon, Jun-Eul Hwang, Jung Hun Kang, Ho Yeong Lim, Changhoon Yoo
Supplementary Table S1. Baseline patient characteristics according to nationality
Supplementary Table S2. Baseline patient characteristics according to AFP response
Supplementary Table S3. Univariate and multivariate analysis for PFS including baseline AFP
Supplementary Table S4. Univariate and multivariate analysis for PFS including AFP response
Supplementary Table S5. Best overall tumor response by baseline AFP and AFP response
